Company: NMP
Filing Date: 2025-07-07
Form Type: 8-K
Source: 0001213900-25-061598
Chunk: 2

Company: NMP Acquisition Corp.
Filing Date: 2025-07-07
Form: 8-K
Item: Item 1.01
Chunk 2
---
 copy of form  
  of which is attached as Exhibit 10.7 hereto and incorporated herein by reference.                                            
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

The Company also issued 400,000
Class A Ordinary Shares to the Representative’s designee as part of the underwriting compensation (the “ Representative Shares”)
on the closing of the IPO. The Representative Shares are identical to the Class A Ordinary Shares included in the Units, except that the
Representative has agreed not to transfer, assign, sell, pledge, or hypothecate any such representative shares, or subject such Representative
Shares to hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by
any person until 180 days immediately following the commencement of sales of the IPO pursuant to FINRA Rule 5110(e)(1), subject to exceptions
pursuant to FINRA Rule 5110(e)(2). The Representative has agreed not to transfer, assign or sell any such Representative Shares without
prior consent of the Company until the completion of the initial business combination. In addition, the Representative has agreed (i)
to waive its redemption rights (or right to participate in any tender offer) with respect to such shares in connection with the completion
of the Company’s initial business combination and (ii) to waive its rights to liquidating distributions from the trust account with
respect to such shares if the Company fails to complete its initial business combination within the period as provided in the Company’s
Amended and Restated Memorandum and Articles of Association (the “ Amended Charter”).

Item 3.02 Unregistered Sales of Equity Securities